Related Experiment Video
Updated: Jun 17, 2026
10:17
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
A distributed, collaborative intelligent agent system approach for proactive postmarketing drug safety surveillance
Yanqing Ji1, Hao Ying, Margo S Farber
1Department of Electrical and Computer Engineering Gonzaga University, Spokane, WA 99258, USA. ji@gonzaga.edu
Summary
A new intelligent agent system, ADRMonitor, proactively detects unknown adverse drug reactions (ADRs) using electronic health records. ADRMonitor significantly outperforms traditional spontaneous reporting in identifying ADR signal pairs and accelerates early detection.
Area of Science:
- Pharmacovigilance
- Artificial Intelligence in Healthcare
- Computational Medicine
Background:
- Postmarketing surveillance is crucial for identifying unknown adverse drug reactions (ADRs).
- Current spontaneous reporting systems are passive, suffer from underreporting, and have reporting delays.
- Proactive detection of ADRs is needed to enhance patient safety.
Purpose of the Study:
- To introduce ADRMonitor, a novel team-based intelligent agent system for proactive ADR detection.
- To evaluate ADRMonitor's performance against traditional spontaneous reporting using simulation experiments.
- To assess the system's ability to accelerate early ADR identification.
Main Methods:
- Developed ADRMonitor, an intelligent agent software system utilizing electronic patient records.
- Simulated healthcare professionals using decision-making models (fuzzy RPD) for both ADRMonitor and spontaneous reporting.
- Conducted simulation experiments with over 275,000 simulated patients based on real patient data.
Main Results:
- ADRMonitor detected 6.6 times more true ADR signal pairs than spontaneous reporting.
- The ADR detection rate of ADRMonitor agents was five times higher than spontaneous reporting.
- ADRMonitor significantly accelerated the early detection of ADRs as patient case numbers increased.
Conclusions:
- ADRMonitor represents a significant advancement over passive spontaneous reporting systems.
- Intelligent agent systems offer enhanced capabilities for proactive pharmacovigilance.
- ADRMonitor has the potential to improve drug safety and accelerate the identification of critical ADRs.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...